Special Featured
Upcoming Live Programs
November 04, 2026
GCP E6(R3): What Inspectors Will Test in Sponsor Oversight
View Details →
November 12, 2026
Excel Spreadsheets – Ensuring Data Integrity and 21 CFR Part 11 Compliance
View Details →
November 13, 2026
Contamination Control Strategy (CCS): Integrating Sterilization, Environmental Monitoring, and Aseptic Operations
View Details →
November 23, 2026
Risk Based Quality Management and Risk Based Monitoring under ICH E6 (R3)
View Details →
November 16, 2026
Determining Root Cause in Sterility Failure Investigations
View Details →
November 18, 2026
Cleaning Validation Lifecycle Control: Monitoring Drift, Method Sensitivity, and Revalidation Decisions
View Details →
November 16, 2026
Using SPC and Process Data to Support Quality, Stability, and Manufacturing Decisions
View Details →
November 10, 2026
Supplier Controls Under QMSR: Risk-Based Oversight, Change Control, and FDA Expectations
View Details →
November 25, 2026
Change Control for SaaS and AI Systems: Managing Configuration Drift and Revalidation Without Creating Validation Backlogs
View Details →
Available for Instant Access
Search or browse on-demand courses available for immediate access.
⌕
Repeat Deviations and OOS: Strengthening RCA-CAPA Effectiveness and Managing Investigation BacklogsSoftware Validation Observations in FDA Warning Letters and Consent Decrees: Patterns, Root Causes, and Remediation ExpectationsRisk Management for AI/ML Medical Devices: Applying ISO 14971 and ISO/TS 24971-2:2026EO Sterilization Validation and Revalidation Under ISO 11135: Practical Implementation and Lifecycle ConsiderationsAI for CAPA and Investigations: Where It Helps and Where It Can Get You in TroubleAcceptance Criteria for AI Validation: Determining What “Reliable” Actually Means in GxP SystemsAseptic Processing and Contamination Control Under EU GMP Annex 1: Practical Applications for Modern Sterile OperationsAudit Trail Review by Exception: Reducing Reviewer Burden Without Weakening DetectionAI-Assisted Post-Market Surveillance and Signal Detection: What Regulators Will Still Expect Humans to DefendRoot Cause Analysis for GMP Investigations: Identifying Systemic Failures and Building Effective CAPAIQ, OQ & PQ: What Now Counts as Sufficient Validation EvidenceChatGPT-Assisted Technical WritingDigital Quality Metrics and AI/ML AnalyticsAI Errors May Be Impossible to Eliminate – What That Means for Its Use in the FDAHPLC Analytical Method Development and ValidationRCA & CAPA: What Inspectors look for Beyond a “Well-Documented” InvestigationValidating AI Use in Quality Systems: Practical CSV and CSA Approaches for FDA Inspection ReadinessEnvironmental Monitoring Programs: Development, Implementation, and Evolving FDA Expectations for Controlled EnvironmentsAI in GMP: What FDA Is Already Expecting - Before You AskInspection Readiness: Defending Your Use of AI to FDA and AuditorsFDA Inspections After QMSR: What Replaces QSIT 2.0 - The New Inspection RealityLeveraging AI in Risk Assessment for Smarter Computer Systems ValidationThe FDA Medical Device File (DHF, DMR, DHR, Market Authorizations) and EU MDR Technical Documentation
No matching courses found.
Training a larger team?
Selected programs can be adapted for organization-wide, site-level, or department-specific delivery.